Trial Profile
A Phase 1 Randomized Double-Blind Placebo-Crossover Safety Trial of DAS181 (Fludase) in Adult Subjects With Well-Controlled Asthma or Bronchiectasis.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 29 Mar 2019
Price :
$35
*
At a glance
- Drugs Oplunofusp (Primary)
- Indications Influenza A virus H1N1 subtype; Influenza A virus H5N1 subtype; Influenza virus infections; Parainfluenza virus infections
- Focus Adverse reactions
- 25 Mar 2019 Status changed from recruiting to completed.
- 25 Mar 2019 Status changed from recruiting to completed.
- 29 Jul 2010 Planned end date changed from 1 May 2010 to 1 Dec 2010 as reported by ClinicalTrials.gov (NCT01113034).